Peptide record

TPDB07604

Antibacterial Anticancer Antifungal Antiparasitic Hemolysis Toxicity standard
14 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB07604
Antibacterial Anticancer Antifungal Antiparasitic Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia AFP-GFuse Antifungipept CAFPdb PD_Hemolysis ToxinPred 3.0
standard
No
A 14-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
INWKALLDAAKKVL
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C75H127N19O18
RCEQGHMFPSTY
ALK
1582.95
10.32
3
1
9
+2
0.04
0.421
153.57
Mammalian: 20 hour Yeast: 30 min E.coli: >10 hour
5500
3.47
1
Residue Composition
number
3
A
0
R
1
N
1
D
0
C
0
E
0
Q
0
G
0
H
1
I
3
L
3
K
0
M
0
F
0
P
0
S
0
T
1
W
0
Y
1
V
Amino Acid Distribution
A: 3 R: 0 N: 1 D: 1 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 1 L: 3 K: 3 M: 0 F: 0 P: 0 S: 0 T: 0 W: 1 Y: 0 V: 1
Chemical Descriptors
14 reviewed residue count
C75H127N19O18 sequence-only estimate (linear, free termini)
1582.95 sequence-only estimate (linear, free termini)
10.32 sequence-only estimate (linear, free termini)
+2 sequence-only estimate (linear, free termini)
0.04 sequence-only estimate (linear, free termini)
0.421 sequence-only estimate (linear, free termini)
Evidence Records 19 records
Evidence 1 Activity

Activity

MIC
Antibacterial
7.8 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against E. coli (MIC 7.8 ug/ml), P. aeruginosa (MIC 62.5 ug/ml), S. aureus (MIC 3.9 ug/ml), and B. subtilis (MIC 3.9 ug/m
Evidence 2 Activity

Activity

MIC
Antibacterial
62.5 µg/mL

Target

Pseudomonas aeruginosa

Source & Reference

dbAMP DRAMP

Other

Active against E. coli (MIC 7.8 ug/ml), P. aeruginosa (MIC 62.5 ug/ml), S. aureus (MIC 3.9 ug/ml), and B. subtilis (MIC 3.9 ug/ml) ( de Souza et al.,2011 ).
Evidence 3 Activity

Activity

MIC
Antibacterial
3.9 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP

Other

Active against E. coli (MIC 7.8 ug/ml), P. aeruginosa (MIC 62.5 ug/ml), S. aureus (MIC 3.9 ug/ml), and B. subtilis (MIC 3.9 ug/ml) ( de Souza et al.,2011 ).
Evidence 4 Activity

Activity

MIC
Antibacterial
3.9 µg/mL

Target

B. subtilis

Source & Reference

dbAMP DRAMP

Other

t E. coli (MIC 7.8 ug/ml), P. aeruginosa (MIC 62.5 ug/ml), S. aureus (MIC 3.9 ug/ml), and B. subtilis (MIC 3.9 ug/ml) ( de Souza et al.,2011 ).
Evidence 5 Activity

Activity

MIC
Antifungal
7.8 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against E. coli (MIC 7.8 ug/ml), P. aeruginosa (MIC 62.5 ug/ml), S. aureus (MIC 3.9 ug/ml), and B. subtilis (MIC 3.9 ug/m
Evidence 6 Activity

Activity

MIC
Antifungal
62.5 µg/mL

Target

Pseudomonas aeruginosa

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against E. coli (MIC 7.8 ug/ml), P. aeruginosa (MIC 62.5 ug/ml), S. aureus (MIC 3.9 ug/ml), and B. subtilis (MIC 3.9 ug/ml) ( de Souza et al.,2011 ).
Evidence 7 Activity

Activity

MIC
Antifungal
3.9 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against E. coli (MIC 7.8 ug/ml), P. aeruginosa (MIC 62.5 ug/ml), S. aureus (MIC 3.9 ug/ml), and B. subtilis (MIC 3.9 ug/ml) ( de Souza et al.,2011 ).
Evidence 8 Activity

Activity

MIC
Antifungal
3.9 µg/mL

Target

B. subtilis

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

t E. coli (MIC 7.8 ug/ml), P. aeruginosa (MIC 62.5 ug/ml), S. aureus (MIC 3.9 ug/ml), and B. subtilis (MIC 3.9 ug/ml) ( de Souza et al.,2011 ).
Evidence 9 Activity

Activity

MIC
Antiparasitic
7.8 µg/mL

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Active against E. coli (MIC 7.8 ug/ml), P. aeruginosa (MIC 62.5 ug/ml), S. aureus (MIC 3.9 ug/ml), and B. subtilis (MIC 3.9 ug/m
Evidence 10 Activity

Activity

MIC
Antiparasitic
62.5 µg/mL

Target

Pseudomonas aeruginosa

Source & Reference

DRAMP

Other

Active against E. coli (MIC 7.8 ug/ml), P. aeruginosa (MIC 62.5 ug/ml), S. aureus (MIC 3.9 ug/ml), and B. subtilis (MIC 3.9 ug/ml) ( de Souza et al.,2011 ).
Evidence 11 Activity

Activity

MIC
Antiparasitic
3.9 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

Active against E. coli (MIC 7.8 ug/ml), P. aeruginosa (MIC 62.5 ug/ml), S. aureus (MIC 3.9 ug/ml), and B. subtilis (MIC 3.9 ug/ml) ( de Souza et al.,2011 ).
Evidence 12 Activity

Activity

MIC
Antiparasitic
3.9 µg/mL

Target

B. subtilis

Source & Reference

DRAMP

Other

t E. coli (MIC 7.8 ug/ml), P. aeruginosa (MIC 62.5 ug/ml), S. aureus (MIC 3.9 ug/ml), and B. subtilis (MIC 3.9 ug/ml) ( de Souza et al.,2011 ).
Evidence 13 Activity

Activity

Hemolysis
[Ref.20108158]ED50 =3.4 × 10−5 M against rat red blood cells

Target

rat red blood cells

Source & Reference

Hemolytik PD_Hemolysis
DRAMP4
Nat Toxins. 1993 1(5):271-276.##Toxicon. 2010 Apr 1 55(4):711-718.##Amino Acids. 2011 Jan 40(1):77-90.

Other

Source Activity Label Source Definition
Hemolysis
Hemolytik experimentally validated hemolytic peptide annotation.
Evidence 14 Activity

Activity

Toxicity
Hemolytic Cytotoxic
- | NA | target cell: Rat erythrocytes

Target

Rat erythrocytes

Source & Reference

NA
DBAASP
The effects of the C-terminal amidation of mastoparans on their biological actions and interactions with membrane-mimetic systems. | Biochim Biophys Acta | 2014
Evidence 15 Activity

Activity

Toxicity
Cytotoxic
- | NA | target cell: Rat mast cells

Target

Rat mast cells

Source & Reference

NA
DBAASP
The effects of the C-terminal amidation of mastoparans on their biological actions and interactions with membrane-mimetic systems. | Biochim Biophys Acta | 2014
Evidence 16 Activity

Activity

50% Hemolysis
Toxicity
34 µM
Hemolytic Cytotoxic
50% Hemolysis | 34 | µM | target cell: Rat erythrocytes

Target

Rat erythrocytes

Source & Reference

NA
DBAASP
Investigating the effect of different positioning of lysine residues along the peptide chain of mastoparans for their secondary structures and biological activities | Amino Acids | 2011
Evidence 17 Activity

Activity

50% Degranulation
Toxicity
80 µM
Cytotoxic
50% Degranulation | 80 | µM | target cell: Rat mast cells

Target

Rat mast cells

Source & Reference

NA
DBAASP
The effects of the C-terminal amidation of mastoparans on their biological actions and interactions with membrane-mimetic systems. | Biochim Biophys Acta | 2014
Evidence 18 Activity

Activity

Toxicity
Hemolytic
Hemolytic_activity: [Ref.20108158]ED50 =3.4 × 10−5 M against rat red blood cells

Target

erythrocytes

Source & Reference

NA
DRAMP
Nat Toxins. 1993 1(5):271-276.##Toxicon. 2010 Apr 1 55(4):711-718.##Amino Acids. 2011 Jan 40(1):77-90.
Evidence 19 Hemolysis

Activity

[Ref.20108158]ED50 =3.4 × 10−5 M against rat red blood cells
Hemolysis

Target

rat red blood cells

Source & Reference

PD_Hemolysis
Nat Toxins. 1993 1(5):271-276.##Toxicon. 2010 Apr 1 55(4):711-718.##Amino Acids. 2011 Jan 40(1):77-90.
DRAMP4
PD_Hemolysis